Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Prediction of outcomes in MCI with (123)I-IMP-CBF SPECT: a multicenter prospective cohort study.

Ito K, Mori E, Fukuyama H, Ishii K, Washimi Y, Asada T, Mori S, Meguro K, Kitamura S, Hanyu H, Nakano S, Matsuda H, Kuwabara Y, Hashikawa K, Momose T, Uchida Y, Hatazawa J, Minoshima S, Kosaka K, Yamada T, Yonekura Y; J-COSMIC Study Group.

Ann Nucl Med. 2013 Dec;27(10):898-906. doi: 10.1007/s12149-013-0768-7. Epub 2013 Sep 6.

2.

Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.

Chiba Y, Iseki E, Fujishiro H, Ota K, Kasanuki K, Suzuki M, Hirayasu Y, Arai H, Sato K.

Psychiatry Res. 2016 Mar 30;249:105-12. doi: 10.1016/j.pscychresns.2015.12.007. Epub 2015 Dec 28.

PMID:
26857415
3.

(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.

Devanand DP, Van Heertum RL, Kegeles LS, Liu X, Jin ZH, Pradhaban G, Rusinek H, Pratap M, Pelton GH, Prohovnik I, Stern Y, Mann JJ, Parsey R.

Am J Geriatr Psychiatry. 2010 Nov;18(11):959-72. doi: 10.1097/JGP.0b013e3181ec8696.

4.

[Prediction of progression in patients with mild cognitive impairment using IMP-SPECT].

Okamura N, Shinkawa M, Arai H, Matsui T, Nakajo K, Maruyama M, Hu XS, Sasaki H.

Nihon Ronen Igakkai Zasshi. 2000 Dec;37(12):974-8. Japanese.

5.

Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study.

Ito K, Fukuyama H, Senda M, Ishii K, Maeda K, Yamamoto Y, Ouchi Y, Ishii K, Okumura A, Fujiwara K, Kato T, Arahata Y, Washimi Y, Mitsuyama Y, Meguro K, Ikeda M; SEAD-J Study Group.

J Alzheimers Dis. 2015;45(2):543-52.

PMID:
25589723
6.

Computer-assisted system for diagnosing degenerative dementia using cerebral blood flow SPECT and 3D-SSP: a multicenter study.

Ishii K, Ito K, Nakanishi A, Kitamura S, Terashima A.

Jpn J Radiol. 2014 Jul;32(7):383-90. doi: 10.1007/s11604-014-0329-6. Epub 2014 May 17.

PMID:
24838777
7.

Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.

Alegret M, Cuberas-Borrós G, Espinosa A, Valero S, Hernández I, Ruíz A, Becker JT, Rosende-Roca M, Mauleón A, Sotolongo O, Castell-Conesa J, Roca I, Tárraga L, Boada M.

J Alzheimers Dis. 2014;41(3):739-48. doi: 10.3233/JAD-132516.

8.

Preoperative central benzodiazepine receptor binding potential and cerebral blood flow images on SPECT predict development of new cerebral ischemic events and cerebral hyperperfusion after carotid endarterectomy.

Sato Y, Ogasawara K, Kuroda H, Suzuki T, Chida K, Fujiwara S, Aso K, Kobayashi M, Yoshida K, Terasaki K, Ogawa A.

J Nucl Med. 2011 Sep;52(9):1400-7. doi: 10.2967/jnumed.111.087940. Epub 2011 Jul 27.

9.

Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP.

Ishii K, Kanda T, Uemura T, Miyamoto N, Yoshikawa T, Shimada K, Ohkawa S, Minoshima S.

Eur J Nucl Med Mol Imaging. 2009 May;36(5):831-40. doi: 10.1007/s00259-008-1051-3. Epub 2009 Jan 16.

PMID:
19148640
10.

Central benzodiazepine receptor binding potential and CBF images on SPECT correlate with oxygen extraction fraction images on PET in the cerebral cortex with unilateral major cerebral artery occlusive disease.

Chida K, Ogasawara K, Kuroda H, Aso K, Kobayashi M, Fujiwara S, Yoshida K, Terasaki K, Ogawa A.

J Nucl Med. 2011 Apr;52(4):511-8. doi: 10.2967/jnumed.110.084186. Epub 2011 Mar 18.

11.

Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.

Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, Zanca M, Portet F, Touchon J, Verny M, Mahieux F, Giron A, Fertil B, Dubois B.

Neurobiol Aging. 2011 Jan;32(1):15-23. doi: 10.1016/j.neurobiolaging.2009.01.013. Epub 2009 Feb 27.

PMID:
19250707
12.

A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.

Alegret M, Cuberas-Borrós G, Vinyes-Junqué G, Espinosa A, Valero S, Hernández I, Roca I, Ruíz A, Rosende-Roca M, Mauleón A, Becker JT, Castell-Conesa J, Tárraga L, Boada M.

J Alzheimers Dis. 2012;30(1):109-20. doi: 10.3233/JAD-2012-111850.

13.

The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.

Hirao K, Ohnishi T, Hirata Y, Yamashita F, Mori T, Moriguchi Y, Matsuda H, Nemoto K, Imabayashi E, Yamada M, Iwamoto T, Arima K, Asada T.

Neuroimage. 2005 Dec;28(4):1014-21. Epub 2005 Aug 29.

PMID:
16129627
14.

Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic.

Kondo D, Ota K, Kasanuki K, Fujishiro H, Chiba Y, Murayama N, Sato K, Hirayasu Y, Arai H, Iseki E.

J Neurol Sci. 2016 Oct 15;369:102-108. doi: 10.1016/j.jns.2016.08.011. Epub 2016 Aug 4.

PMID:
27653873
15.

Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.

Park KW, Yoon HJ, Kang DY, Kim BC, Kim S, Kim JW.

Psychiatry Res. 2012 Aug-Sep;203(2-3):201-6. doi: 10.1016/j.pscychresns.2011.12.007. Epub 2012 Sep 12.

PMID:
22980226
16.

Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.

Mito Y, Yoshida K, Yabe I, Makino K, Hirotani M, Tashiro K, Kikuchi S, Sasaki H.

Clin Neurol Neurosurg. 2005 Aug;107(5):396-403. Epub 2005 Jan 19.

PMID:
16023534
17.

Cerebral blood flow is an earlier indicator of perfusion abnormalities than cerebral blood volume in Alzheimer's disease.

Lacalle-Aurioles M, Mateos-Pérez JM, Guzmán-De-Villoria JA, Olazarán J, Cruz-Orduña I, Alemán-Gómez Y, Martino ME, Desco M.

J Cereb Blood Flow Metab. 2014 Apr;34(4):654-9. doi: 10.1038/jcbfm.2013.241. Epub 2014 Jan 15.

19.

Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.

Grimmer T, Wutz C, Alexopoulos P, Drzezga A, Förster S, Förstl H, Goldhardt O, Ortner M, Sorg C, Kurz A.

J Nucl Med. 2016 Feb;57(2):204-7. doi: 10.2967/jnumed.115.163717. Epub 2015 Nov 19.

20.

Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.

Yoon JH, Kim M, Moon SY, Yong SW, Hong JM.

J Neurol Sci. 2015 Aug 15;355(1-2):174-9. doi: 10.1016/j.jns.2015.06.013. Epub 2015 Jun 10.

PMID:
26076880

Supplemental Content

Support Center